The UK has launched a programme to try to accelerate the discovery and development of new diagnostics and treatments for antimicrobial-resistant (AMR) infections, backed w
In 2017, MSD made the decision to open a $1.32 billion, 220,000 sq ft research facility in the heart of London’s ‘knowledge quarter’ around King’s Cross.
Seven digital health technologies that could help millions of people with lower back pain have been recommended for NHS in draft guidance published by cost-effectiveness o
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has implemented one part of its plan to reform the regulations governing clinical trials, namely an ini
The UK has launched an initiative that will coordinate the activities of two total-body PET imaging centres in England and Scotland, harvesting data that will be made avai
A £1 billion development aimed at creating a major centre for cancer research and treatment in South London has taken a step forwards with the selection of preferred bidde
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.